Jonathan Andrus

Chief Data Officer, Clinical Ink

As Chief Business Officer, Jonathan Andrus is responsible for P&L across all of Clinical Ink’s product lines, leads product management, corporate quality, data privacy and is part of the executive management team where he is focused on helping organizations embrace new technologies and approaches to clinical trial data collection and management. With 20+ years of experience, Mr. Andrus brings extensive expertise developing eClinical services that integrate data and technology to help life science companies optimize study execution.
Mr. Andrus joined Clinical Ink from BioClinica where he led the eClinical Solutions Group to develop their current service offerings, including data management, quality management, implementation services and IWRS. While at BioClinica, Mr. Andrus built relationships and forged strategic partnerships with sponsors, CROs, regulatory bodies, technology developers and clinical research professionals. Prior to BioClinica, Mr. Andrus worked in pharmaceutical consulting and with CROs focused on quality, data management and validation.
An active thought leader, blogger and presenter, Jonathan served as chair of the Society for Clinical Data Management (SCDM) in 2008 and 2014 and currently serves as the society’s Treasurer. He is also an active member of DIA (where he serves on the Annual Conference Program Committee), ASQ and CDISC. He earned his bachelor’s and master’s degrees from Temple University’s College of Liberal Arts and Graduate School of Pharmacy and is a Certified Quality Auditor (CQA) and Certified Clinical Data Manager (CCDM®).